Board of Directors

The Board of Directors of the UVA Licensing & Ventures Group is composed of men and women from a variety of industries, academia and the medical profession. Among this diverse group are experienced entrepreneurs, retired senior executives, medical professionals, UVA faculty and venture capital experts. Meeting quarterly, the board assists the Licensing & Ventures Group in long-range and strategic planning endeavors.

  • Peter Barris

    Position: Managing General Partner, New Enterprise Associates

  • Peter M. Grant, II

    Position: Founding Partner, Anchormarck Holdings, LLC

  • Erik L. Hewlett

    Position: Chair, Board of Directors

  • John S. Lazo

    Position: Associate Dean for Basic Research Professor of Pharmacology & Chemistry, University of Virginia

  • Helga L. Leftwich

    Position: Partner, Hutchison PLLC

  • Michael J. Lenox

    Position: Academic Director and Associate Dean of the Batten Institute, Darden School of Business, University of Virginia

  • Ron Newbold

    Position: Vice President, External R&D Innovation, Pfizer

  • Pamela Norris

    Position: Executive Associate Dean for Research, School of Engineering and Applied Science

  • Phillip A. Parrish

    Position: Interim Vice President for Research, Principal Scientist in the Department of Materials Science & Engineering, Univesity of Virginia

  • Brian A. Pollok

    Position: Founder, President and CEO, Propagenix Inc. and Founder, Neoantigenics

  • Richard P. Shannon

    Position: Executive Vice President for Health Affairs, Louise Nerancy Professor of Health Policy Science, University of Virginia

  • John MacFarlane III

    Position: Managing Partner, Arrochar Management LLC